Skip to main content

Advertisement

SpringerLink
Log in

Current Knowledge on the Pathophysiology of Fanconi Anemia: From Genes to Phenotypes

  • Review Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, bone marrow failure, and leukemia susceptibility. FA cells show chromosome instability and hypersensitivity to DNA cross-linking agents such as mito-mycin C. Recent studies indicate that there are at least 8 genetically distinct FA groups (A, B, C, D1, D2, E, F, G). To date, 6 genes (for A, C, D2, E, F, and G) have been cloned. In this review, we describe the structures and functions of FA proteins. Increasing evidence indicates that the multiple FA proteins cooperate in a biochemical pathway and/or a multimer complex. FANCD2, a downstream component of the FA pathway, has recently been shown to be ubiquitinated in response to DNA damage and to translocate to nuclear foci containing BRCA1, a breast cancer susceptibility gene product, suggesting a role for this protein in DNA repair functions. We also describe 2 emerging issues: genotype-phenotype relationships and mosaicism. The FA pathway is likely to play a critical role as a caretaker of genomic integrity in hematopoietic stem cells. Clarifying the molecular basis of this disease may provide new insights into the pathogenesis of bone marrow failure syndromes and myeloid malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fanconi G. Familiare infantile perinizosaartige Anamia (pernizioses Blutbild and Konstitution).Jahrbuch Kinderheilkda. 1927;117:257–280.

    Google Scholar 

  2. Alter BP. Fanconi’s anemia and malignancies.Am J Hematol. 1996;53:99–110.

    Article  PubMed  CAS  Google Scholar 

  3. Schroeder TM, Tilgen D, Kruger J,Vogel F. Formal genetics of Fanconi’s anemia.Hum Genet. 1976;32:257–288.

    Article  PubMed  CAS  Google Scholar 

  4. Schroeder TM, Anschutz F, Knopp A. Spontane Chromosom-enaberrationen bei familiarer Panmyelopathie.Humangenetik. 1964;1:194–196.

    PubMed  CAS  Google Scholar 

  5. Bloom GE, Warner S, Gerald PS, Diamond LK. Chromosome abnormalities in constitutional aplastic anemia.N Engl J Med. 1966;274:8–14.

    Article  PubMed  CAS  Google Scholar 

  6. Sasaki MS, Tonomura A. A high susceptibility of Fanconi’s anemia to chromosome breakage by DNA cross-linking agents.Cancer Res. 1973;33:1829–1836.

    PubMed  CAS  Google Scholar 

  7. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity.Blood. 1989;73:391–396.

    PubMed  CAS  Google Scholar 

  8. Duckworth-Rysiecki G, Cornish K, Clarke CA, Buchwald M. Identification of two complementation groups in Fanconi anemia.Somat Cell Mol Genet. 1985;11:35–41.

    Article  PubMed  CAS  Google Scholar 

  9. Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9.Nat Genet. 1992;1:196–198.

    Article  PubMed  CAS  Google Scholar 

  10. Joenje H, Lo Ten Foe JR, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype.Blood. 1995;86:2156–2160.

    PubMed  CAS  Google Scholar 

  11. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi’s anaemia by functional complementation.Nature. 1992;356:763–767.

    Article  PubMed  CAS  Google Scholar 

  12. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.Nat Genet. 1996;14:320–323.

    Article  PubMed  CAS  Google Scholar 

  13. The Fanconi anaemia/breast cancer consortium. Positional cloning of the Fanconi anaemia group A gene.Nat Genet. 1996;14:324–328.

    Article  Google Scholar 

  14. de Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anaemia group G geneFANCG is identical with XRCC9.Nat Genet. 1998;20:281–283.

    Article  PubMed  CAS  Google Scholar 

  15. de Winter JP, Rooimans MA, van Der Weel L, et al. The Fanconi anaemia geneFANCF encodes a novel protein with homology to ROM.Nat Genet. 2000;24:15–16.

    Article  PubMed  CAS  Google Scholar 

  16. de Winter JP, Leveille F, van Berkel CG, et al. Isolation of a cDNA Representing the Fanconi Anemia Complementation Group E Gene.Am J Hum Genet. 2000;67:1306–1308.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Timmers C,Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene,FANCD2.Mol Cell. 2001;7:241–248.

    Article  PubMed  CAS  Google Scholar 

  18. Alter BP. Fanconi’s anaemia and its variability.Br J Haematol. 1993;85:9–14.

    Article  PubMed  CAS  Google Scholar 

  19. NS Young, BP Alter. Clinical features of Fanconi’s anemia. In: Young NS, Alter BP, eds.Aplastic anemia, Acquired and Inherited. Philadelphia, Pa: Saunders. 1994:275–309.

    Google Scholar 

  20. Liu JM, Buchwald M, Walsh CE, Young NS. Fanconi anemia and novel strategies for therapy.Blood. 1994;84:3995–4007.

    PubMed  CAS  Google Scholar 

  21. D’Andrea AD, Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy.Blood. 1997;90:1725–1736.

    PubMed  Google Scholar 

  22. Buchwald M, Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage?Mutat Res. 1998;408:75–90.

    Article  PubMed  CAS  Google Scholar 

  23. Garcia-Higuera I, Kuang Y, D’Andrea AD. The molecular and cellular biology of Fanconi anemia.Curr Opin Hematol. 1999;6:83–88.

    Article  PubMed  CAS  Google Scholar 

  24. Liu JM. Fanconi’s anemia. In: Young NS, ed.Bone Marrow Failure Syndromes. Philadelphia, Pa: Saunders; 2000:47–68.

    Google Scholar 

  25. Faivre L, Guardiola P, Lewis C, et al. Association of complementation group and mutation type with clinical outcome in Fanconi anemia.Blood. 2000;96:4064–4070.

    PubMed  CAS  Google Scholar 

  26. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio A P, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study.Blood. 1994;84:1650–1655.

    PubMed  CAS  Google Scholar 

  27. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.Blood. 1996;87:386–392.

    PubMed  CAS  Google Scholar 

  28. Walsh CE, Nienhuis AW, Samulski RJ, et al. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.J Clin Invest. 1994;94:1440–1448.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Fu KL, Foe JR, Joenje H, Rao KW, Liu JM,Walsh CE. Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.Blood. 1997;90:3296–3303

    PubMed  CAS  Google Scholar 

  30. Escarceller M, Buchwald M, Singleton BK, et al. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.J Mol Biol. 1998;279:375–385.

    Article  CAS  PubMed  Google Scholar 

  31. Joenje H, Oostra AB, Wijker M, et al. Evidence for at least eight Fanconi anemia genes.Am J Hum Genet. 1997;61:940–944.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Joenje H, Levitus M,Waisfisz Q, et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.Am J Hum Genet. 2000;67:759–762.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Gibson RA, Buchwald M, Roberts RG, Mathew CG. Characterisation of the exon structure of the Fanconi anaemia group C gene by vectorette PCR.Hum Mol Genet. 1993;2:35–38.

    Article  PubMed  CAS  Google Scholar 

  34. Wevrick R, Clarke CA, Buchwald M. Cloning and analysis of the murine Fanconi anemia group C cDNA.Hum Mol Genet. 1993;2:655–662.

    Article  PubMed  CAS  Google Scholar 

  35. Gibson RA, Hajianpour A, Murer-Orlando M, Buchwald M, Mathew CG. A nonsense mutation and exon skipping in the Fanconi anaemia group C gene.Hum Mol Genet. 1993;2:797–799.

    Article  CAS  PubMed  Google Scholar 

  36. Liebetrau W, Budde A, Savoia A, Grummt F, Hoehn H. p53 activates Fanconi anemia group C gene expression.Hum Mol Genet. 1997;6:277–283.

    Article  CAS  PubMed  Google Scholar 

  37. Tower PA, Christianson TA, Peters ST, et al. Expression of the Fanconi anemia group C gene in hematopoietic cells is not influenced by oxidative stress, cross-linking agents, radiation, heat, or mitotic inhibitory factors.Exp Hematol. 1998;26:19–26.

    CAS  PubMed  Google Scholar 

  38. Kupfer GM, Yamashita T, Naf D, Suliman A, Asano S, D’Andrea AD. The Fanconi anemia polypeptide, FAC, binds to the cyclindependent kinase, cdc2.Blood. 1997;90:1047–1054

    CAS  PubMed  Google Scholar 

  39. Heinrich MC, Silvey KV, Stone S, et al. Posttranscriptional cell cycle-dependent regulation of human FANCC expression.Blood. 2000;95:3970–3977.

    PubMed  CAS  Google Scholar 

  40. Krasnoshtein F, Buchwald M. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients.Hum Mol Genet. 1996;5:85–93.

    Article  CAS  PubMed  Google Scholar 

  41. Hoshino T, Wang J, Devetten MP, et al. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression.Blood. 1998;91:4379–4386.

    CAS  PubMed  Google Scholar 

  42. Kruyt FA, Hoshino T, Liu JM, Joseph P, Jaiswal AK,Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase.Blood. 1998;92:3050–3056.

    CAS  PubMed  Google Scholar 

  43. Hoatlin ME, Zhi Y, Ball H, et al. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.Blood. 1999;94:3737–3747.

    CAS  PubMed  Google Scholar 

  44. Pang Q, Fagerlie S, Christianson TA, et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.Mol Cell Biol. 2000;20:4724–4735.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Pronk JC, Gibson RA, Savoia A, et al. Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3.Nat Genet. 1995;11:338–340.

    Article  CAS  PubMed  Google Scholar 

  46. Centra M, Memeo E, d’Apolito M, et al. Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions.Genomics. 1998;51:463–467.

    Article  CAS  PubMed  Google Scholar 

  47. van de Vrugt HJ, Cheng NC, de Vries Y, et al. Cloning and characterization of murine Fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary.Mamm Genome. 2000;11:326–331.

    Article  PubMed  Google Scholar 

  48. Kruyt FA,Waisfisz Q, Dijkmans LM, et al. Cytoplasmic localization of a functionally active Fanconi anemia group A-green fluorescent protein chimera in human 293 cells.Blood. 1997;90:3288–3295.

    CAS  PubMed  Google Scholar 

  49. Naf D, Kupfer GM, Suliman A, Lambert K, D’Andrea AD. Functional activity of the Fanconi anemia protein FAA requires FAC binding and nuclear localization.Mol Cell Biol. 1998;18:5952–5960.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Lightfoot J, Alon N, Bosnoyan-Collins L, Buchwald M. Characterization of regions functional in the nuclear localization of the Fanconi anemia group A protein.Hum Mol Genet. 1999;8:1007–1015.

    Article  PubMed  CAS  Google Scholar 

  51. Abu-Issa R, Eichele G, Youssoufian H. Expression of the Fanconi anemia group A gene (Fanca) during mouse embryogenesis.Blood. 1999;94:818–824.

    PubMed  CAS  Google Scholar 

  52. Liu N, Lamerdin JE,Tucker JD, et al. The humanXRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells.Proc Natl Acad Sci U S A. 1997;94:9232–9237.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Carreau M, Alon N, Bosnoyan-Collins L, Joenje H, Buchwald M. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups.Mutat Res. 1999;435:103–109.

    Article  PubMed  CAS  Google Scholar 

  54. Whitney M, Thayer M, Reifsteck C, et al. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p.Nat Genet. 1995;11:341–343.

    Article  PubMed  CAS  Google Scholar 

  55. Hejna JA, Timmers CD, Reifsteck C, et al. Localization of the fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3.Am J Hum Genet. 2000;66:1540–1551.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Kupfer GM, Naf D, Suliman A, Pulsipher M, D’Andrea AD. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex.Nat Genet. 1997;17:487–490.

    Article  PubMed  CAS  Google Scholar 

  57. Kruyt FA, Youssoufian H. The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity.Blood. 1998;92:2229–2236.

    PubMed  CAS  Google Scholar 

  58. Yamashita T, Barber DL,Zhu Y, Wu N, D’Andrea AD. The Fanconi anemia polypeptide FACC is localized to the cytoplasm.Proc Natl Acad Sci U S A. 1994;91:6712–6716.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells.Proc Natl Acad Sci U S A. 1994;91:7975–7979.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Hoatlin ME, Christianson TA, Keeble WW, et al. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells.Blood. 1998;91:1418–1425.

    PubMed  CAS  Google Scholar 

  61. McMahon LW, Walsh CE, Lambert MW. Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex.J Biol Chem. 1999;274:32904–32908.

    Article  PubMed  CAS  Google Scholar 

  62. Yamashita T, Kupfer GM, Naf D, et al. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.Proc Natl Acad Sci U S A. 1998;95:13085–13090.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Garcia-Higuera I, Kuang Y, Naf D,Wasik J, D’Andrea AD. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.Mol Cell Biol. 1999;19:4866–4873.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Waisfisz Q, de Winter JP, Kruyt FA, et al. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.Proc Natl Acad Sci U S A. 1999;96:10320–10325.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. Garcia-Higuera I, Kuang Y, Denham J, D’Andrea AD. The Fanconi anemia proteins, FANCA and FANCG, stabilize each other and promote the nuclear accumulation of the FA complex.Blood. 2000;96:3224–3230.

    PubMed  CAS  Google Scholar 

  66. Kruyt FA,Abou-Zahr F, Mok H,Youssoufian H. Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an argininerich domain.J Biol Chem. 1999;274:34212–34218.

    Article  PubMed  CAS  Google Scholar 

  67. Kuang Y, Garcia-Higuera I, Moran A, Mondoux M, Digweed M, D’Andrea AD. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.Blood. 2000;96:1625–1632.

    PubMed  CAS  Google Scholar 

  68. de Winter JP, van Der Weel L, de Groot J, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.Hum Mol Genet. 2000;9:2665–2674.

    Article  PubMed  Google Scholar 

  69. Yamashita T, Garcia-Higuera I, Tetteh N, et al. A cytoplasmic serine protein kinase binds, phosphorylates and regulates the function of the Fanconi anemia protein, FANCA [abstract].Blood. 1999;94:409a.

    Google Scholar 

  70. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway.Mol Cell. 2001;7:249–262.

    Article  PubMed  CAS  Google Scholar 

  71. Hicke L. Gettin’ down with ubiquitin: turning off cell-surface receptors, transporters and channels.Trends Cell Biol. 1999;9:107–112.

    Article  PubMed  CAS  Google Scholar 

  72. Chen JJ, Silver D, Cantor S, Livingston DM, Scully R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.Cancer Res. 1999;59(suppl 7):1752S-1756S.

    PubMed  CAS  Google Scholar 

  73. Deng C-X, Brodie SG. Roles of BRCA1 and its interacting proteins.BioEssays. 2000;22:728–737.

    Article  PubMed  CAS  Google Scholar 

  74. Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2.Nature. 2000;408:429–432.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Karran P. DNA double strand break repair in mammalian cells.Curr Opin Genet Dev. 2000;10:144–150.

    Article  PubMed  CAS  Google Scholar 

  76. Moynahan ME, Chiu JW, Koller BH, Jasin M. Brca1 controls homology-directed DNA repair.Mol Cell. 1999;4:511–518.

    Article  PubMed  CAS  Google Scholar 

  77. Chen M,Tomkins DJ,Auerbach W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia.Nat Genet. 1996;12:448–451.

    Article  PubMed  CAS  Google Scholar 

  78. Whitney MA, Royle G, Low MJ, et al. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.Blood. 1996;88:49–58.

    PubMed  CAS  Google Scholar 

  79. Carreau M, Gan OI, Liu L, et al. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.Blood. 1998;91:2737–2744.

    PubMed  CAS  Google Scholar 

  80. Haneline LS, Broxmeyer HE, Cooper S, et al. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice.Blood. 1998;91:4092–4098.

    PubMed  CAS  Google Scholar 

  81. Rathbun RK, Faulkner GR, Ostroski MH, et al. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.Blood. 1997;90:974–985.

    PubMed  CAS  Google Scholar 

  82. Otsuki T, Nagakura S, Wang J, Bloom M, Grompe M, Liu JM. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.J Cell Physiol. 1999;179:79–86.

    Article  PubMed  CAS  Google Scholar 

  83. Wang J, Otsuki T, Youssoufian H, et al. Overexpression of the Fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis.Cancer Res. 1998;58:3538–3541

    PubMed  CAS  Google Scholar 

  84. Cumming RC, Liu JM, Youssoufian H, Buchwald M. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene.Blood. 1996;88:4558–4567.

    PubMed  CAS  Google Scholar 

  85. Haneline LS, Gobbett TA, Ramani R, et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability.Blood. 1999;94:1–8.

    PubMed  CAS  Google Scholar 

  86. Battaile KP, Bateman RL, Mortimer D, et al. In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia.Blood. 1999;94:2151–2158.

    PubMed  CAS  Google Scholar 

  87. Cheng NC, van De Vrugt HJ, van Der Valk MA, et al. Mice with a targeted disruption of the Fanconi anemia homolog Fanca.Hum Mol Genet. 2000;9:1805–1811.

    Article  PubMed  CAS  Google Scholar 

  88. Auerbach AD, Batish SD, Flit Y, et al. International Fanconi anemia registry (IFAR) update on patients in North America: distribution of complementation groups and genotype-phenotype correlations [abstract].Blood. 2000;96:229a.

    Google Scholar 

  89. Whitney MA, Saito H, Jakobs PM, Gibson RA, Moses RE, Grompe M.A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews.Nat Genet. 1993;4:202–205.

    Article  PubMed  CAS  Google Scholar 

  90. Gibson RA, Morgan NV, Goldstein LH, et al. Novel mutations and polymorphisms in the Fanconi anemia group C gene.Hum Mutat. 1996;8:140–148.

    Article  PubMed  CAS  Google Scholar 

  91. Joenje H. Fanconi anaemia complementation groups in Germany and The Netherlands. European Fanconi Anaemia Research group.Hum Genet. 1996;97:280–282.

    Article  PubMed  CAS  Google Scholar 

  92. Savoia A, Piemontese MR, Savino M, et al. Linkage analysis of Fanconi anaemia in Italy and mapping of the complementation group A gene.Hum Genet. 1997;99:93–97.

    Article  PubMed  CAS  Google Scholar 

  93. Verlander PC, Lin JD, Udono MU, et al. Mutation analysis of the Fanconi anemia gene FACC.Am J Hum Genet. 1994;54:595–601.

    PubMed  PubMed Central  CAS  Google Scholar 

  94. Gavish H, dos Santos CC, Buchwald M. A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein.Hum Mol Genet. 1993;2:123–126.

    Article  PubMed  CAS  Google Scholar 

  95. Lo Ten Foe JR, Barel MT,Thuss P, Digweed M,Arwert F, Joenje H. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant.Hum Genet. 1996;98:522–523.

    Article  PubMed  CAS  Google Scholar 

  96. Verlander PC, Kaporis A, Liu Q, Zhang Q, Seligsohn U, Auerbach AD. Carrier frequency of the IVS4 + 4 A→T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population.Blood. 1995;86:4034–4038.

    PubMed  CAS  Google Scholar 

  97. Savino M, Ianzano L, Strippoli P, et al. Mutations of the Fanconi anemia group A gene (FAA) in Italian patients.Am J Hum Genet. 1997;61:1246–1253.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  98. Levran O, Erlich T, Magdalena N, et al. Sequence variation in the Fanconi anemia gene FAA.Proc Natl Acad Sci U S A. 1997;94:13051–13056.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Morgan NV, Tipping AJ, Joenje H, Mathew CG. High frequency of large intragenic deletions in the Fanconi anemia group A gene.Am J Hum Genet. 1999;65:1330–1341.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  100. Tachibana A, Kato T, Ejima Y, et al. The FANCA gene in Japanese Fanconi anemia: reports of eight novel mutations and analysis of sequence variability.Hum Mutat. 1999;13:237–244.

    Article  PubMed  CAS  Google Scholar 

  101. Nakamura A, Matsuura S, Tauchi H, et al. Four novel mutations of the Fanconi anemia group A gene (FAA) in Japanese patients.J Hum Genet. 1999;44:48–51.

    Article  PubMed  CAS  Google Scholar 

  102. Yamada T, Tachibana A, Shimizu T, Mugishima H, Okubo M, Sasaki MS. Novel mutations of the FANCG gene causing alternative splicing in Japanese Fanconi anemia.J Hum Genet. 2000;45:159–166.

    Article  PubMed  CAS  Google Scholar 

  103. Futaki M,Yamashita T,Yagasaki H, et al. The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.Blood. 2000;95:1493–1498.

    PubMed  CAS  Google Scholar 

  104. Gillio AP, Verlander PC, Batish SD, Giampietro PF, Auerbach AD. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study.Blood. 1997;90:105–110.

    PubMed  CAS  Google Scholar 

  105. Yamashita T, Wu N, Kupfer G, et al. Clinical variability of Fanconi nemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.Blood. 1996;87:4424–4432.

    PubMed  CAS  Google Scholar 

  106. Wolf U. Identical mutations and phenotypic variation.Hum Genet. 1997;100:305–321.

    Article  PubMed  CAS  Google Scholar 

  107. Koc A, Pronk JC,Alikasifoglu M, Joenje H, Altay C. Variable pathogenicity of exon 43del (FAA) in four Fanconi anaemia patients within a consanguineous family.Br J Haematol. 1999;104:127–130.

    Article  PubMed  CAS  Google Scholar 

  108. Lo Ten Foe JR,Kwee ML, Rooimans MA,et al. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance.Eur J Hum Genet. 1997;5:137–148.

    PubMed  CAS  Google Scholar 

  109. Waisfisz Q, Morgan NV, Savino M, et al. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism.Nat Genet. 1999;22:379–383.

    Article  PubMed  CAS  Google Scholar 

  110. Vessey CJ, Norbury CJ, Hickson ID. Genetic disorders associated with cancer predisposition and genomic instability.Prog Nucleic Acid Res Mol Biol. 1999;63:189–221.

    Article  PubMed  CAS  Google Scholar 

  111. Tooze JA, Marsh JC, Gordon-Smith EC. Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria.Lymphoma. 1999;33:231–241.

    Article  CAS  Google Scholar 

  112. Willig TN, Gazda H, Sieff CA. Diamond-Blackfan anemia.Curr Opin Hematol. 2000;7:85–94.

    Article  PubMed  CAS  Google Scholar 

  113. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.Nat Genet. 1999;23:166–175.

    Article  PubMed  CAS  Google Scholar 

  114. Stilgenbauer S, Schaffner C, Litterst A, et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.Nat Med. 1997;3:1155–1159.

    Article  PubMed  CAS  Google Scholar 

  115. Stankovic T, Weber P, Stewart G, et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.Lancet. 1999;353:26–29.

    Article  PubMed  CAS  Google Scholar 

  116. Schaffner C, Stilgenbauer S, Rappold GA, Dohner H, Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.Blood. 1999;94:748–753.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Genetic Diagnosis, Institute of Medical Science, University of Tokyo, Tokyo

    Takayuki Yamashita

  2. Department of Pediatrics, Faculty of Medicine, Kyoto University, Kyoto, Japan

    Tatsutoshi Nakahata

Authors
  1. Takayuki Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tatsutoshi Nakahata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takayuki Yamashita.

About this article

Cite this article

Yamashita, T., Nakahata, T. Current Knowledge on the Pathophysiology of Fanconi Anemia: From Genes to Phenotypes. Int J Hematol 74, 33–41 (2001). https://doi.org/10.1007/BF02982547

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02982547

Key words

Search

Navigation